| |
---|
Cell line: | IARC-139 |
DSMZ no.: | ACC 924 |
Species: | human (Homo sapiens) |
Cell type: | B lymphoblastoid cells |
Origin: | B-lymphoblastoid cell line established in 1982 from normal B-cells of peripheral blood of a 19-year-old man with Burkitt lymphoma. In contrast to autologous BL-30 (DSMZ ACC 916) the IARC-139 carries a wildtype TP53 gene |
Reference(s): | 14714, 40225, 40399, 40234 |
Biosafety level: | 1 |
Permissions and restrictions: | A |
| DSMZ Cell Culture Data: |
Morphology: | mostly round cells growing singly and in aggregates in suspension; image; image |
Medium: | 90% RPMI 1640 + 10% h.i. FBS |
Subculture: | seed out at about 0.5 x 106 cells/ml; split 1:2 to 1:3 every 2-3 days and maintain at 0.3-0.5 x 106 cells/ml (densities above 1 x 106 cells/ml will induce apoptosis) |
Incubation: | at 37 °C with 5% CO2 |
Doubling time: | 48hrs |
Harvest: | maximal density of ca. 1 x 106 cells/ml |
Storage: | frozen with 70% medium, 20% FBS, 10% DMSO |
| DSMZ Scientific Data: |
Mycoplasma: | negative in PCR assay |
Immunology: | CD3 -, CD10 -, CD13 -, CD19 +, CD20 +, CD34 -, CD38 -, CD80 +, CD138 -, HLA-DR +, cyIgG -, cyIgM +, cykappa +, cylambda -; image |
Authenticity: | STR analysis according to the global standard ANSI/ATCC ASN-0002.1-2021 (2021) resulted in an authentic STR profile of the reference STR database, matching the autologous cell line BL-30 |
Molec. Genetics: | wildtype TP53 was verified by sequencing |
Viruses: | PCR: EBV + (the cell line contains an EBV strain that differs from the published B95-8-EBV strain), HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV - |
Supplied as: | Delivery form | | Prices | | Frozen culture | | 450,- € | Growing culture (please inquire for exact delivery time) | | 900,- € | DNA isolated from cell line (25 µg) | | 560,- € | DNA isolated from cell line (5 µg) | | 140,- € | see price list |
| Print data sheet |